News

JD Supra20h
FDA Issues Draft Guidance on Replacing Color Additives in Drug Products
On May 27, 2025, the Food and Drug Administration (FDA) released a new draft guidance, “Replacing Color Additives in Approved or Marketed ...
FDA approves Tryptyr eye drops for dry eye disease
The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...
Pulmonology Advisor2d
FDA Approves Nucala for COPD With an Eosinophilic Phenotype
The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.